BCR and B-cell chronic lymphocytic leukemia: The observation that BCR engagement was still able to induce VLA-4 activation and VLA-4-mediated adhesion in ibrutinib-treated CLL cells, as shown here, could have been caused by a total or partial lack of BTK inhibition in CLL cells.